HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.52) by 17.31 percent. This is a 15.09 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $3.87 million which missed the analyst consensus estimate of $5.72 million by 32.27 percent. This is a 4.11 percent decrease over sales of $4.04 million the same period last year.
Balchem’s Return on Invested Capital Overview
According to Benzinga Pro data Balchem (NASDAQ:BCPC) posted a 15.22% decrease in earnings from Q2. Sales, however, increased…
